(Q24239936)

English

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)

scientific article (publication date: 8 July 2009)

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB) (English)

0 references

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

Leonard Leibovici

6

0 references

4

0 references

object named as

Abigail Fraser

3

0 references

2

object named as

Elad Goldberg

0 references

1

object named as

Edna S Bar-On

0 references

5

object named as

Sarah Hellmann

0 references

publication date

8 July 2009

0 references

Cochrane Database of Systematic Reviews

0 references

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Reactogenicity of DTPa-HBV/Hib vaccine administered as a single injection vs DTPa-HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of age.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Comparative trial to assess the reactogenicity of the diphtheria-tetanus-acellular pertussis (DTPa) vaccine plus Haemophilus influenzae type B (Hib) conjugate vaccine and that of the diphtheria-tetanus-whole cell pertussis (DTPw) vaccine plus Hib co

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity and reactogenicity of DTPw-HB/Hib vaccine administered to colombian infants after a birth dose of hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate v

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Clinical relevance of lower Hib response in DTPa-based combination vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Evaluating the immune response to combination vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

A cohort study of summary reports of controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15 to 18 Months of Age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae Type b Combination Vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

21 January 2018

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility study of the immunogenicity and safety of a novel DTPw/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4, and 6 months of age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a??Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005530.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD005530.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24239936&oldid=2108775738"